Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Thomas

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Research and Practice in Thrombosis and Haemostasis|August 19, 2024
Authors' response to "Venous Thromboembolism Risk Models in Hospitalized Medical Patients: The Time for Implementation, Not Never-Ending Development"Neil A Zakai, Katherine S Wilkinson, Andrew D Sparks, et al.
Research and Practice in Thrombosis and Haemostasis|July 2, 2024
Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) risk scores for venous thromboembolism and bleeding in an independent populationKatherine S Wilkinson, Andrew D Sparks, Mansour Gergi, et al.
Journal of Thrombosis and Thrombolysis|May 18, 2026
Platelet FcɣRIIa: a novel biomarker of risk for thromboembolism and death in cancerChris E Holmes, George A Davis, Heidi S Taatjes-Sommer, et al.
JHLT Open|July 10, 2025
Airway complications after lung transplantation: Perioperative risk factors and clinical outcomesSiddhartha G Kapnadak, Kathleen J Ramos, Rachel Flodin, et al.
Oncotarget|September 15, 2017
The pancreatic tumor microenvironment drives changes in miRNA expression that promote cytokine production and inhibit migration by the tumor associated stromaSong Han, David H Gonzalo, Michael Feely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancyYan Ping Yu, Douglas Landsittel, Ling Jing, et al.
Research Square|October 16, 2023
Longitudinal Microbial and Molecular Dynamics in the Cystic Fibrosis Lung after Elexacaftor-Tezacaftor-Ivacaftor therapyChristian Martin, Douglas V Guzior, Cely T Gonzalez, et al.
Respiratory Research|December 16, 2023
Longitudinal microbial and molecular dynamics in the cystic fibrosis lung after Elexacaftor-Tezacaftor-Ivacaftor therapyChristian Martin, Douglas V Guzior, Cely T Gonzalez, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 26, 2021
A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lungLo M Sosinski, Christian Martin H, Kerri A Neugebauer, et al.
Annals of Surgical Oncology|June 4, 2014
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targetsAndrew X Zhu, Darrell R Borger, Yuhree Kim, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Research and Practice in Thrombosis and Haemostasis|August 19, 2024
Authors' response to "Venous Thromboembolism Risk Models in Hospitalized Medical Patients: The Time for Implementation, Not Never-Ending Development"Neil A Zakai, Katherine S Wilkinson, Andrew D Sparks, et al.
Research and Practice in Thrombosis and Haemostasis|July 2, 2024
Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) risk scores for venous thromboembolism and bleeding in an independent populationKatherine S Wilkinson, Andrew D Sparks, Mansour Gergi, et al.
Journal of Thrombosis and Thrombolysis|May 18, 2026
Platelet FcɣRIIa: a novel biomarker of risk for thromboembolism and death in cancerChris E Holmes, George A Davis, Heidi S Taatjes-Sommer, et al.
JHLT Open|July 10, 2025
Airway complications after lung transplantation: Perioperative risk factors and clinical outcomesSiddhartha G Kapnadak, Kathleen J Ramos, Rachel Flodin, et al.
Oncotarget|September 15, 2017
The pancreatic tumor microenvironment drives changes in miRNA expression that promote cytokine production and inhibit migration by the tumor associated stromaSong Han, David H Gonzalo, Michael Feely, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancyYan Ping Yu, Douglas Landsittel, Ling Jing, et al.
Research Square|October 16, 2023
Longitudinal Microbial and Molecular Dynamics in the Cystic Fibrosis Lung after Elexacaftor-Tezacaftor-Ivacaftor therapyChristian Martin, Douglas V Guzior, Cely T Gonzalez, et al.
Respiratory Research|December 16, 2023
Longitudinal microbial and molecular dynamics in the cystic fibrosis lung after Elexacaftor-Tezacaftor-Ivacaftor therapyChristian Martin, Douglas V Guzior, Cely T Gonzalez, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 26, 2021
A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lungLo M Sosinski, Christian Martin H, Kerri A Neugebauer, et al.
Annals of Surgical Oncology|June 4, 2014
Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targetsAndrew X Zhu, Darrell R Borger, Yuhree Kim, et al.
Pageof 6